Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peyman Hadji

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Journal of Bone Oncology|February 25, 2016
Bone Oncology-An emerging multi-disciplinary specialtyRobert Coleman, Peyman Hadji
MMW Fortschritte Der Medizin|July 25, 2015
[The experiences are uniformly very good]Lorenz Hofbauer, Peyman Hadji
Journal of Bone Oncology|February 25, 2016
JBO-Launched and flying aheadRobert Coleman, Peyman Hadji
Seminars in Oncology|December 11, 2007
Reducing the risk of cancer treatment-associated bone loss in patients with breast cancerPeyman Hadji, Nigel Bundred
Lancet (London, England)|June 5, 2015
Denosumab and fracture risk in women with breast cancerRobert Coleman, Peyman Hadji
Deutsches Arzteblatt International|July 5, 2013
Correspondence (reply): In replyPeyman Hadji, Silvia Klein
Breast Care (Basel, Switzerland)|March 12, 2015
Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancerMatthias Kalder, Peyman Hadji
Journal of Geriatric Oncology|April 20, 2016
Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in GermanyLouis Jacob, Peyman Hadji, Karel Kostev
Geburtshilfe Und Frauenheilkunde|July 29, 2022
Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral FracturesPeyman Hadji, Niki Mouzakiti, Ioannis Kyvernitakis
Critical Reviews in Oncology/Hematology|July 11, 2013
Bone effects of mammalian target of rapamycin (mTOR) inhibition with everolimusPeyman Hadji, Robert Coleman, Michael Gnant
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Journal of Bone Oncology|February 25, 2016
Bone Oncology-An emerging multi-disciplinary specialtyRobert Coleman, Peyman Hadji
MMW Fortschritte Der Medizin|July 25, 2015
[The experiences are uniformly very good]Lorenz Hofbauer, Peyman Hadji
Journal of Bone Oncology|February 25, 2016
JBO-Launched and flying aheadRobert Coleman, Peyman Hadji
Seminars in Oncology|December 11, 2007
Reducing the risk of cancer treatment-associated bone loss in patients with breast cancerPeyman Hadji, Nigel Bundred
Lancet (London, England)|June 5, 2015
Denosumab and fracture risk in women with breast cancerRobert Coleman, Peyman Hadji
Deutsches Arzteblatt International|July 5, 2013
Correspondence (reply): In replyPeyman Hadji, Silvia Klein
Breast Care (Basel, Switzerland)|March 12, 2015
Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancerMatthias Kalder, Peyman Hadji
Journal of Geriatric Oncology|April 20, 2016
Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in GermanyLouis Jacob, Peyman Hadji, Karel Kostev
Geburtshilfe Und Frauenheilkunde|July 29, 2022
Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral FracturesPeyman Hadji, Niki Mouzakiti, Ioannis Kyvernitakis
Critical Reviews in Oncology/Hematology|July 11, 2013
Bone effects of mammalian target of rapamycin (mTOR) inhibition with everolimusPeyman Hadji, Robert Coleman, Michael Gnant
Pageof 18